Subin Zacharia

Subin Zacharia

Active Director Director DIN 02490573
DIN 02490573 First appointment May 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 1 historical roles
Total affiliations 8 Since May 2009
Shareholding value •••• Premium profile

About Subin Zacharia

Data last updated:

Subin Zacharia is a Director at Veros Healthcare Private Limited (since 2009), Director at Verogen Healthcare Private Limited (since 2014) and Designated Partner at Jwfn Growth Llp (since 2026), and holds 4 more current directorships. The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹10.62 Cr; the largest is Veros Healthcare Private Limited at ₹10.34 Cr (FY 2024). Earlier, Subin Zacharia was a Director at Levana Pharmaceuticals And Surgicals Private Limited (from 2009).

DIN 02490573
Primary Designation Director
Industry Pharma
First Appointment 28 May 2009
Oldest Company Age 17 yrs
Largest company Veros Healthcare Private Limited · ₹10.34 Cr (FY 2024)
Combined revenue ₹10.62 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Veros Healthcare Private Limited U24230TN2009PTC096776
Director17 Nov 20092009₹10.34 Cr (FY 2024)Active
Verogen Healthcare Private Limited U24100TN2014PTC094601
Director16 Jan 20142014₹28.2 Lakh (FY 2022)Active
Jwfn Growth Llp ADC-8213
Designated Partner30 Sep 20262026Active
Fnso Strat Llp ADA-0606
Designated Partner16 Jul 20262026Active
Mgfn Strat Llp ACT-4394
Designated Partner12 Dec 20252025Active
Partner02 Sep 20242024Active
Designated Partner04 Sep 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 May 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Siaa Vida Pharmaceuticals Llp
Verogen Healthcare Private Limited
Veros Healthcare Private Limited
Levana Pharmaceuticals And Surgicals Private Limited
Premium access

Shareholding and investment profile for Subin Zacharia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subin Zacharia

Subin Zacharia currently holds 7 directorships: Veros Healthcare Private Limited (Director, since 17 Nov 2009, revenue ₹10.34 Cr (FY 2024)); Verogen Healthcare Private Limited (Director, since 16 Jan 2014, revenue ₹28.2 Lakh (FY 2022)); Jwfn Growth Llp (Designated Partner, since 30 Sep 2026); Fnso Strat Llp (Designated Partner, since 16 Jul 2026); Mgfn Strat Llp (Designated Partner, since 12 Dec 2025); and 2 more.

Subin Zacharia was first appointed on 28 May 2009 as Director at Levana Pharmaceuticals And Surgicals Private Limited. The most recent appointment on record is 30 Sep 2026 at Jwfn Growth Llp.

The 2 current companies of Subin Zacharia that report revenue have a combined latest revenue of ₹10.62 Cr: Veros Healthcare Private Limited ₹10.34 Cr (FY 2024); Verogen Healthcare Private Limited ₹28.2 Lakh (FY 2022).

Subin Zacharia held 1 earlier board appointment: Levana Pharmaceuticals And Surgicals Private Limited (Director, from 28 May 2009).

The current boards of Subin Zacharia's companies include Abhin Nair (Veros Healthcare Private Limited), Lizil Paul Cherakkal (Veros Healthcare Private Limited), Manjula Devi Sridharan (Veros Healthcare Private Limited), Kapil Kumar Bhawarlal Jain (Verogen Healthcare Private Limited), Rahul Jain (Verogen Healthcare Private Limited), Sidharth Pande (Jwfn Growth Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available